Declared value of physician sample packs prevails; pro rata revaluation and extended limitation fail absent suppression.

Physician sample packs of medicaments, when sold to wholesale dealers at declared prices, were to be valued on the actual declared sale price under Section 4(1)(a) of the Central Excise Act, 1944; a notional pro rata valuation based on larger commercial packs was not sustainable. The extended limitation period under the proviso to Section 11A(1) could not be invoked because the department knew of manufacture and clearances, statutory returns were filed, audits were conducted, and no suppression or concealment was established. As the valuation dispute and demand failed on merits and limitation, the related penalties and interest also could not survive.

---

---

Issues: (i) Whether physician sample packs of medicaments were liable to be valued by applying a pro rata basis or whether the declared sale price under Section 4(1)(a) of the Central Excise Act, 1944 had to be accepted. (ii) Whether the demand was barred by limitation because the extended period under the proviso to Section 11A(1) of the Central Excise Act, 1944 was not invocable. (iii) Whether the penalties and interest imposed could survive when the demand itself was unsustainable.

Issue (i): Whether physician sample packs of medicaments were liable to be valued by applying a pro rata basis or whether the declared sale price under Section 4(1)(a) of the Central Excise Act, 1944 had to be accepted.

Analysis: The physician sample packs were themselves sold to wholesale dealers at declared prices. The goods in smaller packs were treated as a distinct manufactured product, and once the sale price was not shown to be incorrect, valuation could not be reworked merely by comparing them with larger commercial packs and applying a pro rata price. The declared price of the physician sample packs, therefore, was the proper assessable value.

Conclusion: The valuation adopted by the assessee was correct and the pro rata revaluation was not sustainable.

Issue (ii): Whether the demand was barred by limitation because the extended period under the proviso to Section 11A(1) of the Central Excise Act, 1944 was not invocable.

Analysis: The manufacture and clearance of physician sample packs were known to the department, statutory documents were filed regularly, and the unit was audited from time to time. On these facts, there was no positive suppression or concealment of material facts to justify invocation of the extended period.

Conclusion: The demand was barred by limitation and the extended period was not available to the department.

Issue (iii): Whether the penalties and interest imposed could survive when the demand itself was unsustainable.

Analysis: Once the valuation dispute and the demand failed on merits and on limitation, the foundation for penal action and related interest also disappeared.

Conclusion: The penalties and interest were not sustainable.

Final Conclusion: The duty demand, interest, and penalties were set aside, and the appeals succeeded in full.

Ratio Decidendi: Where physician sample packs are actually sold at a declared price and the department fails to establish suppression of material facts, their assessable value cannot be substituted by a notional pro rata value, and the extended period of limitation cannot be invoked without proof of deliberate concealment.

---